Telmisartan is an angiotensin II receptor antagonist (ARB). These are marketed by Boehringer Ingelheim under a tradename Micardis®. Telmisartan is too marketed by Glaxo Class action Ltd under a trademark Pritor®. Arbitrageur come prescribed primarily in the professional assistance of high blood pressure.

Newly studies indicate that telmisartan could as well stand PPARγ agonistic properties that can possibly confer beneficial metabolic results. This observation is presently existence explored within clinical test.